{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:26:34Z","timestamp":1779377194871,"version":"3.53.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015286","name":"Hebei Provincial Key Research Projects","doi-asserted-by":"publisher","award":["20250496"],"award-info":[{"award-number":["20250496"]}],"id":[{"id":"10.13039\/501100015286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.anndiagpath.2025.152560","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T15:58:50Z","timestamp":1757001530000},"page":"152560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Diagnostic value of SSTR2A, ATRX, and clusterin immunohistochemical expression in high-grade gastroenteropancreatic neuroendocrine neoplasms"],"prefix":"10.1016","volume":"80","author":[{"given":"Yutong","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saisai","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.anndiagpath.2025.152560_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188637","article-title":"Gastroenteropancreatic neuroendocrine neoplasms G3: novel insights and unmet needs","volume":"1876","author":"Shi","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"7","key":"10.1016\/j.anndiagpath.2025.152560_bb0010","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Pavel","year":"2020","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152560_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188367","article-title":"Molecular subtyping in pancreatic neuroendocrine neoplasms: new insights into clinical, pathological unmet needs and challenges","volume":"1874","author":"Yan","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.anndiagpath.2025.152560_bb0020","first-page":"14","article-title":"2020 Chinese consensus on the pathological diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasms experts group. [Chinese consensus on the pathological diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasms (2020)]","volume":"50","author":"Division of Digestive Diseases, Chinese Society of Pathology","year":"2021","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152560_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-6498-z","article-title":"P53, somatostatin receptor 2a and chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms","volume":"20","author":"Nielsen","year":"2020","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.anndiagpath.2025.152560_bb0030","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1158\/1078-0432.CCR-16-1113","article-title":"Alternative lengthening of telomeres and loss of DAXX\/ATRX expression predicts metastatic disease and poor survival in patients with pancreatic neuroendocrine tumors","volume":"23","author":"Singhi","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.anndiagpath.2025.152560_bb0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.soc.2019.11.003","article-title":"Pathologic considerations in gastroenteropancreatic neuroendocrine tumors","volume":"29","author":"Bellizzi","year":"2020","journal-title":"Surg Oncol Clin N Am"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152560_bb0040","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/his.13408","article-title":"Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases","volume":"72","author":"Singhi","year":"2018","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.anndiagpath.2025.152560_bb0045","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3748\/wjg.v28.i10.1009","article-title":"An update on the diagnosis of gastroenteropancreatic neuroendocrine neoplasms","volume":"28","author":"Fang","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152560_bb0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152560_bb0055","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1158\/1078-0432.CCR-15-0548","article-title":"Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: a pathway distinct from poorly differentiated neuroendocrine carcinomas","volume":"22","author":"Tang","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152560_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13099","article-title":"Clinicopathological and molecular profile of grade 3 gastroenteropancreatic neuroendocrine neoplasms","volume":"34","author":"Taboada","year":"2022","journal-title":"J Neuroendocrinol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152560_bb0065","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11154-020-09607-z","article-title":"Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer","volume":"22","author":"Klomp","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152560_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030775","article-title":"Somatostatin receptor 2 expression profiles and their correlation with the efficacy of somatostatin analogues in gastrointestinal neuroendocrine tumors","volume":"14","author":"Watanabe","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"23","key":"10.1016\/j.anndiagpath.2025.152560_bb0075","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1002\/cncr.28341","article-title":"Clinicopathologic characteristics of pancreatic neuroendocrine tumors and relation of somatostatin receptor type 2A to outcomes","volume":"119","author":"Okuwaki","year":"2013","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152560_bb0080","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3892\/etm.2021.10613","article-title":"The new WHO classification of gastrointestinal neuroendocrine tumors and immunohistochemical expression of somatostatin receptor 2 and 5","volume":"22","author":"Popa","year":"2021","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.anndiagpath.2025.152560_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111174","article-title":"Clusterin: always protecting. Synthesis, function and potential issues","volume":"134","author":"Rodr\u00edguez-Rivera","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.anndiagpath.2025.152560_bb0090","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/his.12450","article-title":"Clusterin expression in gastrointestinal neuroendocrine tumours is highly correlated with location and is helpful in determining the origin of liver metastases","volume":"65","author":"Mourra","year":"2014","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.anndiagpath.2025.152560_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188500","article-title":"Clusterin as modulator of carcinogenesis: a potential avenue for targeted cancer therapy","volume":"1875","author":"Praharaj","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152560_bb0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2559.2007.02608.x","article-title":"Clusterin is highly expressed in pancreatic endocrine tumours but not in solid pseudopapillary tumours","volume":"50","author":"Mourra","year":"2007","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152560_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/genes14040790","article-title":"ATRX\/DAXX: guarding the genome against the hazards of ALT","volume":"14","author":"Clatterbuck Soper","year":"2023","journal-title":"Genes"},{"issue":"6021","key":"10.1016\/j.anndiagpath.2025.152560_bb0110","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.anndiagpath.2025.152560_bb0115","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1158\/1078-0432.CCR-16-1147","article-title":"Alternative lengthening of telomeres in primary pancreatic neuroendocrine tumors is associated with aggressive clinical behavior and poor survival","volume":"23","author":"Kim","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.anndiagpath.2025.152560_bb0120","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/gutjnl-2020-322595","article-title":"Non-functional pancreatic neuroendocrine tumours: ATRX\/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX\/PDX1 expression and tumour size","volume":"71","author":"Hackeng","year":"2022","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152560_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2022.100065","article-title":"Integrated genomic and clinicopathologic approach distinguishes pancreatic Grade 3 neuroendocrine tumor from neuroendocrine carcinoma and identifies a subset with molecular overlap","volume":"36","author":"Umetsu","year":"2023","journal-title":"Mod Pathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109291342500125X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109291342500125X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T22:05:05Z","timestamp":1764281105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109291342500125X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":25,"alternative-id":["S109291342500125X"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152560","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic value of SSTR2A, ATRX, and clusterin immunohistochemical expression in high-grade gastroenteropancreatic neuroendocrine neoplasms","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152560","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152560"}}